CTRI/2023/07/054765
Not yet recruiting
未知
A prospective observational study- To study the efficacy of IPACK (Infiltration between the popliteal artery and capsule of knee joint) after unilateral TKA.(Total Knee Arthroplasty) - IPACK
Bhagwan Mahaveer jain, hospital0 sites0 target enrollmentTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Health Condition 1: O- Medical and Surgical
- Sponsor
- Bhagwan Mahaveer jain, hospital
- Status
- Not yet recruiting
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •American Society of Anesthesiologist (ASA) physical status score I\-III
- •Scheduled for elective unilateral TKA
- •Age \> 18 and \< 80 years
- •BMI \< 40 kg/m2
Exclusion Criteria
- •American Society of Anesthesiologist (ASA) physical status score (ASA) IV
- •Patients on any anticoagulant
- •Age \< 18 and \> 80 years
- •Pregnant women
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
Prospective observational study to examine the effect of chemotherapy on the microbiota of pancreatic cancer.pancreatic cancerJPRN-UMIN000049816Wakayama Medical University10
Completed
Not Applicable
Role of transcutaneous nerve stimulation at external ear for pain relief and haemodynamic stability of heart surgery patientHealth Condition 1: I089- Rheumatic multiple valve disease,unspecifiedCTRI/2020/05/025464SGPGIMS Lucknow
Completed
Not Applicable
Observational prospective study to evaluate the efficacy of Vitamin K Intravenously on the coagulopathy in patients with peroxisomal biogenesis disorders (PBD)congenital metabolic diseasesPeroxisomal biogenesis disorderzellweger syndrome spectrum1006447710021605NL-OMON42020Kinderhematologie5
Recruiting
Not Applicable
Prospective observational study to evaluate the effect of supercritical carbon dioxide processed acellular dermal matrix(SC DERM® Recon) in prosthetic breast reconstructioNeoplasmsKCT0008722Asan Medical Center50
Recruiting
Not Applicable
ong delayed emesis induced by cancer chemotherapy can be suppressed by NK1 receptor antagonist (LODEC-N)JPRN-jRCT1030230130Seiichiro Kuroda100